Spectrascience New Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Spectrascience New current Real Value cannot be determined due to lack of data. The regular price of Spectrascience New is $0.0. Our model measures the value of Spectrascience New from inspecting the company fundamentals such as Price To Earning of (0.04) X, return on asset of -0.92, and EBITDA of (1.99 M) as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Spectrascience New's valuation include:
Enterprise Value 492.4 K | Enterprise Value Ebitda (0.14) | Price Sales 73.0729 | Enterprise Value Revenue 2 K |
Undervalued
Today
Please note that Spectrascience New's price fluctuation is out of control at this time. Calculation of the real value of Spectrascience New is based on 3 months time horizon. Increasing Spectrascience New's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Spectrascience stock is determined by what a typical buyer is willing to pay for full or partial control of Spectrascience New. Since Spectrascience New is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Spectrascience Stock. However, Spectrascience New's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0 | Real 0.0 | Hype 0.0 |
The real value of Spectrascience Stock, also known as its intrinsic value, is the underlying worth of Spectrascience New Company, which is reflected in its stock price. It is based on Spectrascience New's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Spectrascience New's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Spectrascience New helps investors to forecast how Spectrascience stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Spectrascience New more accurately as focusing exclusively on Spectrascience New's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Spectrascience New's intrinsic value based on its ongoing forecasts of Spectrascience New's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Spectrascience New's closest peers. If more than one evaluation category is relevant for Spectrascience New we suggest using both methods to arrive at a better estimate.
Spectrascience New Cash |
|
Spectrascience Valuation Trend
Comparing Spectrascience New's enterprise value against its market capitalization is a good way to estimate the value of Spectrascience New uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Spectrascience New Total Value Analysis
Spectrascience New is at this time forecasted to have valuation of 492.38 K with market capitalization of 492.38 K, debt of 6.38 M, and cash on hands of 27.88 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Spectrascience New fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
492.38 K | 492.38 K | 6.38 M | 27.88 K |
Spectrascience New Investor Information
The company recorded a loss per share of 0.01. Spectrascience New had not issued any dividends in recent years. The entity had 1:100 split on the 18th of November 2003. Based on the key measurements obtained from Spectrascience New's financial statements, Spectrascience New may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Spectrascience New Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Spectrascience New has an asset utilization ratio of 0.37 percent. This indicates that the Company is making $0.003715 for each dollar of assets. An increasing asset utilization means that Spectrascience New is more efficient with each dollar of assets it utilizes for everyday operations.Spectrascience New Profitability Analysis
The company reported the previous year's revenue of 5.15 K. Net Loss for the year was (4.47 M) with loss before overhead, payroll, taxes, and interest of (194.25 K).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Spectrascience New's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Spectrascience New and how it compares across the competition.
About Spectrascience New Valuation
The stock valuation mechanism determines Spectrascience New's current worth on a weekly basis. Our valuation model uses a comparative analysis of Spectrascience New. We calculate exposure to Spectrascience New's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Spectrascience New's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -174.8 K | -166.1 K | |
| Pretax Profit Margin | (997.39) | (947.52) | |
| Operating Profit Margin | (545.79) | (518.50) | |
| Net Loss | (997.39) | (947.52) | |
| Gross Profit Margin | (43.38) | (41.21) |
Spectrascience New Current Valuation Indicators
Valuation refers to the process of determining the present value of Spectrascience New and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Spectrascience we look at many different elements of the entity such as Spectrascience's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Spectrascience New, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Spectrascience New's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Spectrascience New's worth.Complementary Tools for Spectrascience Stock analysis
When running Spectrascience New's price analysis, check to measure Spectrascience New's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spectrascience New is operating at the current time. Most of Spectrascience New's value examination focuses on studying past and present price action to predict the probability of Spectrascience New's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spectrascience New's price. Additionally, you may evaluate how the addition of Spectrascience New to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Directory Find actively traded commodities issued by global exchanges |